Linyi Peoples Hospital

Linyi, Shandong 276005

3 studies enrolling now · 9 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Advanced Solid Tumor, Ankylosing Spondylitis, High-risk Transient Ischemic Attack, Metastatic Non-small Cell Lung Cancer, Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Non-small Cell Lung Cancer, Prevention of Ischemic Stroke, Primary Sjogrens Disease, Refractory Chronic Lymphocytic Leukemia, Refractory Diffuse Large B-cell Lymphoma

Studies at this site

• Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors — Recruiting now
• A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202) — Recruiting now
• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients — Recruiting now
• A Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer — Running, not enrolling
• A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies — Stopped early
• A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome — Running, not enrolling
• A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer — Running, not enrolling
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis — Stopped early